Drug Development Pharma - November 21, 2013
Medivir’s Simeprivir approved in Canada
Medivir AB has announced that Health Canada has approved as a new treatment for hepatitis C. Simeprevir will be approved for the treatment of chronic hepatitis C (CHC) genotype 1 infection, in combination with peginterferon alfa and ribavirin in adults with compensated liver disease, including cirrhosis, who are treatment‑naïve or who have failed previous interferon therapy […]
Drug Development Pharma - November 20, 2013
Sobi gets EU approval for Kineret
Sobi has announced that the European Commission (EC) has approved Kineret (anakinra) for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS). The decision follows a positive opinion adopted by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) in September 2013, states the company. The approval was based on the outcome […]
Uncategorized - November 20, 2013
Head of new translational research centre appointed
Karolinska Institutet and AstraZeneca has recruited Professor Bo Angelin to lead the Integrated Cardio Metabolic Centre (ICMC). Bo Angelin is a Professor of Clinical Metabolism at Karolinska Institutet and a senior consultant at the Department of Endocrinology, Metabolism & Diabetes at Karolinska University Hospital. He is an internationally renowned researcher in the field of lipid metabolism. […]
In a new job - November 20, 2013
Probi appoints new CEO
Swedish biotechnology company Probi has appointed Peter Nählstedt as its new CEO. Peter Nählstedt has extensive experience from the international life science industry through various executive positions involving strategy, marketing and sales at GE Healthcare Life Science, states the company in a press release. Peter Nählstedt joins Probi from Trelleborg Marine Systems where he has […]
Uncategorized - November 19, 2013
Grants to 15 life science companies
A total of 64 research companies get to share SEK 65 million in Vinnova’s latest dividend of Forska och Väx funding. Among the companies are 15 life science firms. Each of the 15 companies get grants between SEK 500 000 and SEK 3 500 000. Follicum and Hansa Medical are two of companies getting most […]
MedTech Award - November 19, 2013
SCA medtech company of the year
Global hygiene firm SCA has been named medtech company of the year by Swedish Medtech. “We are proud and happy to receive the prize. With this prestigious award we have been recognized for our progress within medical technology. We have only just scratched the surface of the great needs existing but there are also large improvements within […]
